Taiyu Investment
VC Fund
Beijing, China
Taiyu Investment is an investment firm.
- Total investments:
- 51
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Taiyu Investment invests in
Stages Taiyu Investment invests in
Countries Taiyu Investment invests in
Round sizes
Round size
- Seed
- $2.8M–$20M
- Angel
- $434k–$100M
- Series A
- $14M–$37M
Investment Focus
Industry
- Medical 23 (45%)
- Health Care 16 (31%)
- Biotechnology 14 (27%)
- Medical Device 10 (20%)
- Pharmaceutical 8 (16%)
Stage
- Seed 16 (31%)
- Series A 16 (31%)
- Angel 7 (14%)
- Series B 5 (10%)
- Series C 4 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Danuo Intelligent Technology
|
Danuo Intelligent Technology is dedicated to promoting the application of trustworthy AI in the life sciences field. | $1.5M / Angel / Oct 14, 2026 | |
Allygen Biologics
|
Allygen Biologics is a biotechnology company that provides research and development of targeted conjugate therapeutics. | $44.8M / Series A / Oct 13, 2026 | |
| Immunocan focuses on the development of fully human antibody animals, artificial chromosome carriers with independent intellectual property rights, focusing on tumor treatment, and developing antibody therapeutic drugs. | $36.8M / Series A / May 13, 2026 | ||
Rhino Medical
|
Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments | $14.5M / Series B / Mar 27, 2026 | |
| Infineon Multiomics is a biotechnology company that provides research and application of space multiomics technology. | $7.4M / Seed / Mar 24, 2026 | ||
Juhai Hengchuang
|
Juhai Hengchuang is a medical device manufacturer that exclusively sells and manufactures drug testing equipment. | Seed / Mar 18, 2026 | |
| QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases. | $72.8M / Series C / Mar 02, 2026 | ||
Greenon Biotech
|
Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on. | $14.2M / Series B / Dec 22, 2025 | |
Micro Interventional
|
Micro Interventional is a company that develops active interventional innovative medical devices. It emphasizes the development of novel medical devices with a product strategy centered on the precise interventional treatment of coronary heart disease and peripheral arterial disease. | Series A / Dec 16, 2025 | |
| BV Laser is a manufacturer of medical beauty equipment. | $14.2M / Series C / Dec 15, 2025 | ||
| See all 51 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Taiyu Investment invest in?
Taiyu Investment invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 51 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Taiyu Investment invest in?
Taiyu Investment typically joins rounds of $2.8M–$20M at Seed, $434k–$100M at Angel and $14M–$37M at Series A. These are whole funding-round sizes, not Taiyu Investment's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Taiyu Investment took part in.
When did Taiyu Investment last invest?
The most recent investment recorded for Taiyu Investment closed in Oct 2026. Shizune tracks 51 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
